New Alzheimer’s drug raises hopes — along with questions

FHS
August 11, 2023
10:48 am

The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and a precursor condition, mild cognitive impairment.

FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated | Psychedelic Invest

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company“), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the

September 18, 2023

Local Virginia governments add to insulin lawsuits against Eli Lilly, Novo Nordisk, Sanofi, others

An eastern Virginia county filed suit against Eli Lilly, Novo Nordisk, Sanofi and a handful of pharmacy benefit managers last week over insulin prices. It’s

November 28, 2023

Vitalchat Integrates Inpatient Telehealth with Samsung Healthcare TVs

What You Should Know: – Inpatient telehealth innovator Vitalchat announced today an integration partnership with Samsung healthcare TV displays. – The Vitalchat app, which offers

October 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.